Cat.#: ACPP-1200
| Despition | PAX8 Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1522 | Dopamine Receptor D3 Blocking Peptide (AC1522) | 250 µg | inquiry |
| ACPP-1446 | Human NDP Protein (AC1446) | 2 µg | inquiry |
| ACPP-1435 | Human CHGA Protein, His (AC1435) | 2 µg | inquiry |
| ACPP-1382 | Human EYA2 Protein (AC1382) | 2 µg | inquiry |
| ACPP-1701 | Human SERPINA3 Protein (AC1701) | 5 µg | inquiry |
| ACPP-1051 | Recombinant Human Amyloid Precursor Protein Protein (6×His Tag) (AC1051) | 50 µg | inquiry |
| ACPP-1152 | PAX5 Blocking Peptide (AC1152) | 250 µg | inquiry |
| ACPP-1104 | Human IL 6 Protein (AC1104) | 5 µg | inquiry |
| ACPP-1528 | Human RCAN3 Protein (AC1528) | 2 µg | inquiry |
| ACPP-1205 | Human MECP2 Protein (AC1205) | 2 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.